Les NRJ Music Awards 2026 en direct sur TF1 vendredi 23 octobre 2026
zurl.co/TDe2v
#NMA #NMA2026 #NRJMusicAwards #Artistes #Invites #Cannes #TF1 #NRJ

Les NRJ Music Awards 2026 en direct sur TF1 vendredi 23 octobre 2026
zurl.co/TDe2v
#NMA #NMA2026 #NRJMusicAwards #Artistes #Invites #Cannes #TF1 #NRJ
Random walks reveal how uncertainty moves through a network meta-analysis—and where variance diagnostics can expose weak links.
https://www.mattheneus.com/editorial/network-meta-analysis-diffusion-random-walk-variance-diagnostics-2026-10-15
#HTA #NMA #EvidenceSynthesis
When the comparator bridge fails, added benefit can remain unproven—even with active-treatment evidence. https://www.mattheneus.com/editorial/g-ba-iqwig-benralizumab-hes-mepolizumab-indirect-comparison-infeasible-2026-10-15 #HTA #NMA #EvidenceSynthesis #RegulatoryAffairs
Three trials, no head-to-head: a network meta-analysis compares neoadjuvant bladder-cancer strategies. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/pubmed-bladder-cancer-neoadjuvant-ddmvac-durvalumab-network-meta-analysis-2026-10-15
Scotland accepts atogepant for acute migraine after an indirect class comparison—what the Bayesian network evidence means for HTA decisions. https://www.mattheneus.com/editorial/smc-atogepant-aquipta-acute-migraine-bayesian-network-comparison-2026-10-12 #HTA #NMA #EvidenceSynthesis #Pharma
Top-ranked doesn’t mean decision-ready: why transfusion-threshold evidence in acute brain injury still needs an audit. https://www.mattheneus.com/editorial/acute-brain-injury-transfusion-threshold-bayesian-nma-evidence-audit-2026-10-12 #HTA #NMA #EvidenceSynthesis
SMC accepts obinutuzumab for lupus nephritis—but comparator uncertainty remains in the evidence base. https://www.mattheneus.com/editorial/smc-gazyvaro-obinutuzumab-lupus-nephritis-regency-nma-flare-model-2026-10-12 #HTA #NMA #EvidenceSynthesis #Pharma
Treatment rankings after stroke can shift by outcome—and wide prediction intervals temper confidence. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/frontiers-post-stroke-shoulder-hand-syndrome-rehabilitation-network-prediction-intervals-2026-09-23
Treatment packages can rank well in an NMA while hiding which component drives outcomes. https://www.mattheneus.com/editorial/pubmed-robot-assisted-prostatectomy-component-identifiability-network-meta-analysis-2026-10-12 #HTA #NMA #EvidenceSynthesis
Why can a promising therapy still miss HTA approval? This SMC decision shows how comparative and economic uncertainty can outweigh clinical promise. https://www.mattheneus.com/editorial/smc-inavolisib-itovebi-non-recommendation-inavo120-nma-economic-uncertainty-2026-10-12 #HTA #NMA #RWE
📢 DU Revues Systématiques et Méta-Analyses en Santé : ouverture des candidatures !
📆 Candidatures ouvertes jusqu'au 30/11 — Ne ratez pas votre chance !
Info et candidature ➡️ t.ly/t_YdX
#formation #médecine #recherche #revuesystématique #nma #metaanalyse #santépublique #publichealth
Resistance training ranks highest for cognition across AD, Parkinson’s and MCI, with low-certainty evidence.
https://www.mattheneus.com/editorial/frontiers-cognitive-exercise-network-alzheimer-parkinson-mci-low-certainty-2026-10-10
#HTA #NMA #EvidenceSynthesis
Which therapy leads in kidney protection? A Bayesian network analysis compares SGLT2 inhibitors, semaglutide and finerenone. https://www.mattheneus.com/editorial/frontiers-diabetic-kidney-disease-sglt2-semaglutide-finerenone-bayesian-network-2026-10-09 #HTA #NMA #EvidenceSynthesis
Pregnancy signals can outrank live-birth evidence in chronic endometritis. See why endpoint hierarchy matters in network meta-analysis. https://www.mattheneus.com/editorial/pubmed-chronic-endometritis-nma-live-birth-endpoint-hierarchy-2026-10-08 #HTA #NMA #EvidenceSynthesis
Time-specific estimands can determine whether a paediatric antiemetic network answers the clinical question you intended. https://www.mattheneus.com/editorial/paediatric-antiemetic-nma-time-window-estimand-governance-2026-10-04 #HTA #NMA #EvidenceSynthesis
Which postoperative sedative best reduces delirium, and what trade-offs follow? This network meta-analysis maps the benefit-risk picture. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/pubmed-dexmedetomidine-postoperative-intensive-care-delirium-bradycardia-network-2026-10-02
Which lifestyle options improve cardiometabolic outcomes in PCOS? A Bayesian network analysis maps the evidence. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/pubmed-polycystic-ovary-syndrome-lifestyle-bayesian-network-meta-analysis-2026-10-09
"I'll tell you what I'll do I'll make the first one free,
And when you want some more just come back to me"
Crohn's disease location can reshape comparative treatment efficacy and the network meta-analysis question. https://www.mattheneus.com/editorial/pubmed-crohns-disease-location-treatment-efficacy-nma-2026-10-08 #HTA #NMA #EvidenceSynthesis
How do perioperative chemotherapy cycle strategies compare in gastric cancer? A new network meta-analysis maps the evidence. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/world-journal-gastric-cancer-perioperative-cycle-network-meta-analysis-2026-10-08